Skip to main content
Premium Trial:

Request an Annual Quote

Exiqon Certifies Denmark's Aros to Provide miRNA PCR Services

Premium

Exiqon said this week that it has certified Aros Applied Biotechnology, a genomic services firm based in Aarhus, Denmark, to provide real-time PCR services based on Exiqon’s miRcury LNA Universal RT microRNA PCR product line.

The agreement, part of Exiqon’s certified service provider program, will create a Center of Excellence at Aros.

“We see an increased demand for high-quality miRNA analysis from both pharmaceutical companies and research institutions," said Brian Sørensen, CEO at Aros, in a statement.

Likewise, Henrik Pfundheller, senior vice president of sales and marketing at Exiqon, said that the company is seeing "an increasing demand for microRNA profiling from body fluids such as serum/plasma and urine, and we are confident that we have a strong partner in Aros.”

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.